DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cineline India vs Nifty 50: Share Price Performance Compared

Univest 4 hrs ago·11 Sept 2026, 4:20 am

Cineline India has underperformed the benchmark Nifty 50 index over the past year. While the broader market has seen significant growth, the stock has struggled to keep pace, reflecting a disconnect between the company's performance and the broader market sentiment.

This divergence matters to investors as it signals that Cineline India may be facing specific challenges, such as operational hurdles or a lack of investor confidence. For those holding the stock, it highlights the importance of monitoring the company's fundamentals and future growth prospects.

Investors should watch for any updates on the company's operational strategy and market share. A turnaround in performance or a shift in market conditions could be key factors to consider before making any investment decisions.